Fennec Pharmaceuticals (FENC) Amortization - Deferred Charges (2019 - 2025)
Fennec Pharmaceuticals (FENC) has disclosed Amortization - Deferred Charges for 7 consecutive years, with $12000.0 as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Amortization - Deferred Charges fell 42.86% year-over-year to $12000.0, compared with a TTM value of $63000.0 through Sep 2025, down 52.99%, and an annual FY2024 reading of $89000.0, down 68.99% over the prior year.
- Amortization - Deferred Charges was $12000.0 for Q3 2025 at Fennec Pharmaceuticals, down from $13000.0 in the prior quarter.
- Across five years, Amortization - Deferred Charges topped out at $73000.0 in Q2 2023 and bottomed at $7000.0 in Q1 2022.
- Average Amortization - Deferred Charges over 5 years is $33800.0, with a median of $21000.0 recorded in 2024.
- The sharpest move saw Amortization - Deferred Charges crashed 97.75% in 2021, then skyrocketed 928.57% in 2023.
- Year by year, Amortization - Deferred Charges stood at $8000.0 in 2021, then soared by 775.0% to $70000.0 in 2022, then changed by 0.0% to $70000.0 in 2023, then crashed by 64.29% to $25000.0 in 2024, then tumbled by 52.0% to $12000.0 in 2025.
- Business Quant data shows Amortization - Deferred Charges for FENC at $12000.0 in Q3 2025, $13000.0 in Q2 2025, and $13000.0 in Q1 2025.